Navigation Links
Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Date:12/3/2009

risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2009 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx® are trademarks of Cardium Therapeutics, Inc.

Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM), Excellagen(TM), Excellarate(TM) and Osteorate(TM) are trademarks of Tissue Repair Company.

SOURCE Cardium Therapeutics


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
2. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
3. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
4. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
7. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
8. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
9. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
10. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
11. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation ... generic market entry results in $5.4 billion in lost ... analysis by economic consulting firm Matrix Global ... Required by the Food and Drug ... programs are intended to improve drug safety by ensuring ...
(Date:7/23/2014)... -- Top Staten Island Pediatrician Dr. Michael ... which discusses tips for parents about pool safety for children. ... According to US News article, "Drowning is the ... aged 1 to 4, and can occur in as little ... the article says that watching a child in the water ...
(Date:7/23/2014)... PositiveID Corp. (OTCQB: PSID), based in ... emerging player in the bio-threat detection market, that ... rapid medical testing. The Company,s proprietary airborne pathogen ... Detector), was developed under contract with the U.S. ... directorate, and $30 million of contract funding. ...
Breaking Medicine Technology:New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2
... VANCOUVER, Canada, March 21, 2012  – bioTheranostics, Inc. ... presented at the United States and Canadian Academy ... ID® had strong clinical utility and ... classification and sub-classification. Tumor classification and sub-classification are ...
... /PRNewswire-iReach/ -- Global Information Inc. is excited ... 8th Annual World Health Care Congress ... : European healthcare systems may be diverse, but the all ... common by health systems across the entire world, and many ...
Cached Medicine Technology:New Studies Demonstrate Clinical Utility and Validity of CancerType ID® Molecular Classifier 2New Studies Demonstrate Clinical Utility and Validity of CancerType ID® Molecular Classifier 3New Studies Demonstrate Clinical Utility and Validity of CancerType ID® Molecular Classifier 48th Annual World Health Care Congress Set for Amsterdam, Spring 2012 2
(Date:7/23/2014)... Adipic acid is an intermediate ... high-performance plastic, often referred to as engineering thermoplastics. ... on the monomers employed. Due to the high ... the increasing number of developing countries, the Asia-Pacific ... followed by Europe and North America. Adipic acid ...
(Date:7/23/2014)... News) -- Children and teens who lose a parent might ... a new study suggests. People who were children or ... risk of death during the study period than those who ... the report. Although the study found an association between ... death, it wasn,t designed to prove cause-and-effect. Also, the ...
(Date:7/23/2014)... at the emergency department, the drug ketamine can ... life-saving intubation, despite decades-old studies that suggested it ... systematic review of 10 recent studies of what ... are published online in Annals of Emergency ... Intracranial and Cerebral Perfusion Pressure and Health Outcomes: ...
(Date:7/23/2014)... 2014 SafeUseNow? , a ... developed by Principled Strategies , today announced ... California . Utilizing SafeUseNow’s patent-pending risk model, Partnership ... misusing and abusing controlled substance drugs, particularly prescription ... its members. , The agreement with Partnership HealthPlan ...
(Date:7/23/2014)... RFcnn.com, a distinguished electrical equipment retailer, has recently unveiled ... more, the company has decided to provide big price cuts ... an order for the company’s brand new SMA JACK can ... The high quality SMA JACK from RFcnn.com Provides a great ... electrical equipment to help make things much easier for worldwide ...
Breaking Medicine News(10 mins):Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4Health News:New Collection of SMA JACK Released by China Electrical Accessory Manufacturer RFcnn 2
... GENEVA, Switzerland, December 15 Swiss-based, http://www.dnartistic.com ,s first ... million CHF and some of the proceeds will be ... of sister company, http://www.inneova.com . , ... Swiss scientist specialized in molecular,genetics of aging and co-founder ...
... Cross sheltered hundreds of people over the weekend who were affected ... Cross chapters opened shelters in Maine, Massachusetts, New Hampshire, New York ... ice storms are par for the course during the New England ... a safe and warm place to go when there are widespread ...
... VPHM ) today provided the following update regarding ... The Food and Drug Administration (FDA) has posted draft ... draft guidance is open for public comment, and if finalized ... the in vitro dissolution testing originally proposed in ...
... Dec. 15 Anthem Blue Cross and Blue Shield,(Anthem) ... life and health insurance organization, announced today that,Summerlin is ... for,its members and employer groups as it exits the ... an agreement that facilitates,the smooth transition of current Summerlin ...
... under age 65 were without health insurance for all or ... by the UCLA Center for Health Policy Research. ... California Health Interview Survey (CHIS), the policy brief,s authors found ... all or some of 2007, the most recent year for ...
... Education Virtual Lecture for Healthcare Professionals , ... Cytomegalovirus (CMV) infection is a serious condition and an ... hematopoietic stem cell transplant (HSCT) and solid organ transplant ... prevention. It is important for healthcare professionals working with ...
Cached Medicine News:Health News:DNA Jewel to Finance Anti-Aging Services & Cancer Research 2Health News:Red Cross Shelters Hundreds as Severe Weather Hits Northeast 2Health News:ViroPharma Provides Update on Vancocin(R) 2Health News:ViroPharma Provides Update on Vancocin(R) 3Health News:ViroPharma Provides Update on Vancocin(R) 4Health News:Anthem Blue Cross and Blue Shield and Summerlin Life and Health Insurance Company Enter Into Endorsement Agreement as Summerlin Announces Exit From the Commercial PPO Business in Nevada 2Health News:Anthem Blue Cross and Blue Shield and Summerlin Life and Health Insurance Company Enter Into Endorsement Agreement as Summerlin Announces Exit From the Commercial PPO Business in Nevada 3Health News:Nearly 6.4 million Californians lack health insurance, report shows 2Health News:CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion 2
... The Isoseeds I-125 are brachytherapy sources ... treatment of localized tumors, especially in the ... after the conclusion of the therapeutic effect, ... I-125 are intended for single use. They ...
Mirror prismatic gonioscope. Titanium body....
Four 62 mirrors give a 360 view of the anterior chamber angle with only a slight lens rotation. Posterior pole can be viewed through center of lens....
... mirrors allow complete observation ... little lens rotation. Small ... for eyes with small ... ring available in small ...
Medicine Products: